Corgi每日2倍做多ONTO主动型ETF ONTX 深 沪
等待开盘 10-16 09:30:00 美东时间
10.26
-0.720
-6.56%
华盛通- 最 高10.26
- 今 开9.69
- 成交量 1.88万股
- 最 低 9.2095
- 昨 收 10.98
- 总市值 76.95万
- 52周最高 43.14
- 市盈率 静 9.38
- 换手率 25.09%
- 52周最低 9.2095
- 委 比 -0.71%
- 总股本 7.50万
- 历史最高 43.14
- 量 比 2.61
- 振 幅 9.57%
- 历史最低 9.2095
- 每 手 1
- 风险率 4.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Traws Pharma GAAP EPS of -$4.87
Traws Pharma press release (NASDAQ:TRAW): Q2 GAAP EPS of -$4.87. More on Traws Pharma Seeking Alpha’s Quant Rating on Onconova Therapeutics Historical earnings data for Onconova Therapeutics Financial...
2024-08-15 19:16
Onconova slips after all-stock merger with Trawsfynydd
Onconova Therapeutics (NASDAQ:ONTX) traded lower on Tuesday after the company acquired privately-held biotech Trawsfynydd Therapeutics, in an all-stock transaction following a definitive merger agreem...
2024-04-03 02:02
Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket
Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading.
2023-12-11 20:59
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Onconova Therapeutics (NASDAQ:ONTX) shares moved upwards by 42.5% to $...
2023-12-09 05:30
Onconova Therapeutics's Earnings: A Preview
Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earning...
2023-11-14 01:01
Onconova Therapeutics Announces Rigosertib Data Presented At EADV As Late Breaker
Onconova Therapeutics, Inc. (NASDAQ:ONTX), ("Onconova", the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that a
2023-10-12 20:09
Onconova Therapeutics Analyst Ratings
What is the target price for Onconova Therapeutics (ONTX)?The latest price targ...
2023-08-11 08:11
HC Wainwright & Co. Reiterates Buy on Onconova Therapeutics, Maintains $11 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates Onconova Therapeutics (NASDAQ:ONTX) with a Buy and maintains $11 price target.
2023-05-16 18:25
Onconova Therapeutics: Q1 Earnings Insights
Onconova Therapeutics (NASDAQ:ONTX) reported its Q1 earnings results on Monday,...
2023-05-16 04:25
